Roland Newman
- Molecular Biology top 5%
- Immunology top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Hematology top 1%
- Oncology top 5%
- Co-authors
- Melvyn F. GreavesC. SchneiderRobert SutherlandD. Robert SutherlandD DeliaJ. T. KemsheadP. J. KleinG. Uhlenbruck
- Topics
- Monoclonal and Polyclonal Antibodies Research (34 papers)Glycosylation and Glycoproteins Research (24 papers)T-cell and B-cell Immunology (8 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Roland Newman
68 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Biology 2.1k
- Immunology 1.5k
- Radiology, Nuclear Medicine and Imaging 1.3k
- Hematology 770
- Oncology 577
Countries citing papers authored by Roland Newman
This map shows the geographic impact of Roland Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Newman more than expected).
Fields of papers citing papers by Roland Newman
This network shows the impact of papers produced by Roland Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Newman. The network helps show where Roland Newman may publish in the future.
Co-authorship network of co-authors of Roland Newman
This figure shows the co-authorship network connecting the top 25 collaborators of Roland Newman. A scholar is included among the top collaborators of Roland Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Newman. Roland Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 24 | |
| 3 | 25 | |
| 4 | 36 | |
| 5 | 16 | |
| 6 | 45 | |
| 7 | 97 | |
| 8 | 15 | |
| 9 | 15 | |
| 10 | High-performance capillary electrophoresis measurement of dolastatin-10 | 2 |
| 11 | 25 | |
| 12 | Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin. | 34 |
| 13 | 112 | |
| 14 | 66 | |
| 15 | 33 | |
| 16 | 41 | |
| 17 | 300 | |
| 18 | 135 | |
| 19 | 6 | |
| 20 | 14 |
About Roland Newman
Roland Newman is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Endocrinology, having authored 69 papers that have together received 4.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (24 papers) and T-cell and B-cell Immunology (8 papers). The work is most often cited by research in Immunology (1.5k citations), Hematology (770 citations) and Radiology, Nuclear Medicine and Imaging (1.3k citations). Roland Newman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Melvyn F. Greaves, C. Schneider, Robert Sutherland, D. Robert Sutherland, D Delia, J. T. Kemshead, P. J. Klein, G. Uhlenbruck, Tucker W. LeBien and JH Kersey. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.